CYP 8.16% 22.5¢ cynata therapeutics limited

Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-496

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    all these words will haunt you when it's approved and manufacturing at scale LOL how could you not see it haha.


    That was funny toooooo @Barman76

    S: "Quite frankly I am staggered that you think Novartis would be willing to sign an agreement in November 2020 to help scale up manufacture of MSC’s with Mesoblast , if it thought that Mesoblast was going to have problems with cell harvesting."
    R: Signed using a pencil at this stage it seems:

    yep, spot on. cart before the horse like stocks of cells before approval. its a problem.

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.020(8.16%)
Mkt cap ! $40.68M
Open High Low Value Volume
24.5¢ 24.5¢ 22.5¢ $32.92K 143.1K

Buyers (Bids)

No. Vol. Price($)
1 21235 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 17528 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.